Denali Therapeutics Inc. 10-Q, 10-Q/A, 10-QT, and 10-QT/A reports

Location
161 Oyster Point Blvd., South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/6/2024, 04:18 PM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Nov 6, 2024 Sep 30, 2024
10-Q Report | Data 10-Q Aug 1, 2024 Jun 30, 2024
10-Q Report | Data 10-Q May 7, 2024 Mar 31, 2024
10-Q Report | Data 10-Q Nov 7, 2023 Sep 30, 2023
10-Q Report | Data 10-Q Aug 8, 2023 Jun 30, 2023
10-Q Report | Data 10-Q May 8, 2023 Mar 31, 2023
10-Q Report | Data 10-Q Nov 3, 2022 Sep 30, 2022
10-Q Report | Data 10-Q Aug 8, 2022 Jun 30, 2022
10-Q Report | Data 10-Q May 5, 2022 Mar 31, 2022
10-Q Report | Data 10-Q Nov 4, 2021 Sep 30, 2021
10-Q Report | Data 10-Q Aug 4, 2021 Jun 30, 2021
10-Q Report | Data 10-Q May 5, 2021 Mar 31, 2021
10-Q Report | Data 10-Q Nov 5, 2020 Sep 30, 2020
10-Q Report | Data 10-Q Aug 7, 2020 Jun 30, 2020
10-Q Report | Data 10-Q May 7, 2020 Mar 31, 2020
10-Q Report | Data 10-Q Nov 6, 2019 Sep 30, 2019
10-Q Report | Data 10-Q Aug 6, 2019 Jun 30, 2019
10-Q Report | Data 10-Q Q1 2019 May 8, 2019 Mar 31, 2019
10-Q/A Report 10-Q/A Dec 6, 2018 Jun 30, 2018
10-Q Report | Data 10-Q Nov 8, 2018 Sep 30, 2018
10-Q Report | Data 10-Q Aug 9, 2018 Jun 30, 2018
10-Q Report | Data 10-Q May 11, 2018 Mar 31, 2018